CHOLINE MAGNESIUM TRISALICYLATE
- CAS NO.:64425-90-7
- Empirical Formula: C26H29MgNO10
- Molecular Weight: 539.81
- MDL number: MFCD01746271
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-03-13 11:54:02
What is CHOLINE MAGNESIUM TRISALICYLATE?
Toxicity
Salicylate intoxication, known as salicylism, may occur with large doses or extended therapy. Common symptoms of salicylism include headache, dizziness, tinnitus, hearing impairment, confusion, drowsiness, sweating, vomiting, diarrhea, and hyperventilation. A more severe degree of salicylate intoxication can lead to CNS disturbances, alteration in electrolyte balance, respiratory and metabolic acidosis, hyperthermia, and dehydration.
The Uses of CHOLINE MAGNESIUM TRISALICYLATE
The antipyretic and analgesic effect of Choline magnesium trisalicylate is similar to that of aspirin, but the adverse reaction is less than that of aspirin, and the curative effect is better than that of aspirin and ibuprofen. It is indicated for the relief of symptoms of rheumatoid arthritis, osteoarthritis, and other arthritic conditions, both in the acute onset and in the long-term treatment of these diseases. The gastrointestinal reaction is small, so it is especially suitable for patients who cannot tolerate aspirin.
Background
Choline magnesium trisalicylate is a non-acetylated salicylate used widely as a nonsteroidal anti-inflammatory drug. Trisalicylate significantly reduces methotrexate renal clearance, displacing methotrexate from protein, increasing the fraction unbound by 28% .
Indications
Choline magnesium trisalicylate is used to reduce pain and inflammation caused by conditions such as arthritis. This medication is also used to treat fever in adults.
Pharmacokinetics
Trisalicylate-choline is a non-steroidal anti-inflammatory drug (NSAID) that contains a combination of choline salicylate and magnesium salicylate. Does not affect platelet aggregation.
Side Effects
①Active peptic ulcer, hemophilia and allergic to salicylates should not be used. Pregnant women and children under 12 years old are prohibited. ②Use with caution in patients with chronic renal insufficiency and acute erosive gastritis. ③ This product should not be used at the same time as coumarin anticoagulant or heparin. Concomitant use with steroids or alcohol may increase ulcer bleeding. ④ Occasionally rash, fever and stomach discomfort.
Metabolism
Not Available
Safety information for CHOLINE MAGNESIUM TRISALICYLATE
New Products
4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID 4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium 3-Bromopyrazole (3aR,4R,5R,6aS)-hexahydro-5-Triethyl silyloxy-4-((E)-3-oxo-5-phenylpent-1- enyl)cyclopenta[b]furan-2-one. 1-Chlorocarbonyl-4-piperidinopiperidine 1-Bromo-4-phenyl-2-Butanone 4-Amino-2-fluoro-N-methylbenzamide 1,1'-Carbonyldiimidazole SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTIONRelated products of tetrahydrofuran
You may like
-
Dimethyl [2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate 99%View Details
54094-19-8 -
85-81-4 99%View Details
85-81-4 -
Cyclopentane carboxxylic acid 3400-45-1 99%View Details
3400-45-1 -
208111-98-2 (3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten- 1-yl]-2H-cyclopenta[b]furan-2-one 99%View Details
208111-98-2 -
2033-24-1 99%View Details
2033-24-1 -
Meldrums acid 2033-24-1 99%View Details
2033-24-1 -
Cyaclopentane carboxylic acid 99%View Details
3400-45-1 -
2-Aminopyridine 504-29-0 99%View Details
504-29-0